CRISPR-Cas Technology, the Tool of the Future

Alejandro Esquivel Álvarez, Elías Quesada Morales, María Paz Villegas Calero, Daniela Matarrita Brenes, María Fernanda Rojas Salas, German Madrigal Redondo, Marianela Chavarría Rojas and Eleaneth Baltodano Viales
Additional contact information
Alejandro Esquivel Álvarez: University of Costa Rica, Costa Rica
Elías Quesada Morales: University of Costa Rica, Costa Rica
María Paz Villegas Calero: University of Costa Rica, Costa Rica
Daniela Matarrita Brenes: Universidad de Costa Rica, Costa Rica
María Fernanda Rojas Salas: University of Costa Rica, Costa Rica
German Madrigal Redondo: University of Costa Rica, Costa Rica
Marianela Chavarría Rojas: University of Costa Rica, Costa Rica
Eleaneth Baltodano Viales: University of Costa Rica, Costa Rica

European Journal of Biology and Biotechnology, 2022, vol. 3, issue 2, 1-9

Abstract: The CRISPR-Cas system discovered in the eighties consists of a series of RNA proteins that signal and messengers of the immune system in prokaryotic organisms to protect against invading antigens of various sources. After the CRISPR-Cas discovery, many research advances were made in the following decades regarding knowledge, techniques, and applications. This showed the system could edit the DNA in an exact and specific manner, which made it very promising to exploit it in various fields, such as the therapeutic field. New therapies of various diseases, industrial applications, food manufacturing, among others, make its impact quite relevant. The following review will focus on the fundamental understanding and implications of CRISPR-Cas techniques has with an ethical and legal view. In addition, to explore some of the applications present and future in the healthcare department, some methods of drug delivery in gene therapy, and new research that is being developed with the CRISPR-Cas technology.

Keywords: CRISPR-Cas; DNA; gene; pharmacy; RNA; therapy (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejbio/article/view/17332 Abstract page (text/html)
https://eu-opensci.org/index.php/ejbio/article/download/17332/4247 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejbio0:v:3:y:2022:i:2:id:17332

DOI: 10.24018/ejbio.2022.3.2.332

Access Statistics for this article

More articles in European Journal of Biology and Biotechnology from European Open Science
Bibliographic data for series maintained by Support Team ().